Publications by authors named "A Lapitz"

Claim this Profile
T
Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talk.
Paula Olaizola, Irene Olaizola, Marta Fernandez de Ara, Ainhoa Lapitz, Beatriz Val

Hepatology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas.
Irene Olaizola, Mikel Odriozola-Gimeno, Paula Olaizola, Francisco J Caballero-Camino, Noelia Pastor-Toyos, Ainhoa Lapitz

J Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4-/- mice.
Cristina Di Giorgio, Ginevra Urbani, Carmen Massa, Silvia Marchianò, Michele Biagioli, Ainhoa Lapitz

Hepatol Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential.
Maria Mercado-Gómez, Naroa Goikoetxea-Usandizaga, Alvaro Eguileor Giné, Miguel A Merlos Rodrigo, Marta Bento Afonso, Ainhoa Lapitz

Gut· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic Profiling of Extracellular Vesicles in Inflammatory Bowel Diseases.
Montse Baldán-Martín, Mikel Azkargorta, Ainhoa Lapitz, Lorena Ortega Moreno, Ibon Iloro

Int J Mol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis